{"disease":{"id":"bilirubin-encephalopathy","name":"bilirubin encephalopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04584983","title":"Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":134,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":true},{"nct_id":"NCT03534466","title":"Evaluation of Long-Term Gait Development in Infants With Neonatal Encephalopathy Using Infant Treadmill","phase":"NA","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT03527498","title":"Evaluation of Long-term Neurodevelopment in Neonatal Encephalopathy by Infant Treadmill","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}